RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
U-Neuron Biomedical Stock

U-Neuron Biomedical Net Income 2024

U-Neuron Biomedical Net Income

-84.89 M TWD

Ticker

6973.TWO

ISIN

TW0006973001

In 2024, U-Neuron Biomedical's profit amounted to -84.89 M TWD, a 96.64% increase from the -43.17 M TWD profit recorded in the previous year.

The U-Neuron Biomedical Net Income history

YEARNET INCOME (undefined TWD)
2023-
2022-
2021-

U-Neuron Biomedical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into U-Neuron Biomedical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by U-Neuron Biomedical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects U-Neuron Biomedical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of U-Neuron Biomedical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into U-Neuron Biomedical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing U-Neuron Biomedical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on U-Neuron Biomedical’s growth potential.

U-Neuron Biomedical Revenue, EBIT and net profit per share

DateU-Neuron Biomedical RevenueU-Neuron Biomedical EBITU-Neuron Biomedical Net Income
202327.02 M undefined-90.32 M undefined-84.89 M undefined
202226.79 M undefined-43.68 M undefined-43.17 M undefined
202128.42 M undefined-15.07 M undefined-11.26 M undefined

U-Neuron Biomedical stock margins

The U-Neuron Biomedical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of U-Neuron Biomedical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for U-Neuron Biomedical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the U-Neuron Biomedical's sales revenue. A higher gross margin percentage indicates that the U-Neuron Biomedical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the U-Neuron Biomedical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the U-Neuron Biomedical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the U-Neuron Biomedical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the U-Neuron Biomedical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the U-Neuron Biomedical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

U-Neuron Biomedical Margin History

U-Neuron Biomedical Gross marginU-Neuron Biomedical Profit marginU-Neuron Biomedical EBIT marginU-Neuron Biomedical Profit margin
202379.78 %-334.24 %-314.14 %
202280.56 %-163.04 %-161.15 %
202184.21 %-53.02 %-39.62 %

U-Neuron Biomedical Aktienanalyse

What does U-Neuron Biomedical do?

U-Neuron Biomedical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding U-Neuron Biomedical's Profit Margins

The profit margins of U-Neuron Biomedical represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of U-Neuron Biomedical's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating U-Neuron Biomedical's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

U-Neuron Biomedical's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When U-Neuron Biomedical’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about U-Neuron Biomedical stock

How much profit has U-Neuron Biomedical made this year?

U-Neuron Biomedical has made -84.89 M TWD this year.

How has the profit developed compared to last year?

The profit has increased by 96.64% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does U-Neuron Biomedical publish its earnings?

U-Neuron Biomedical publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of U-Neuron Biomedical?

The profits of U-Neuron Biomedical are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of U-Neuron Biomedical?

You can learn more about the earnings of U-Neuron Biomedical by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does U-Neuron Biomedical pay?

Over the past 12 months, U-Neuron Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, U-Neuron Biomedical is expected to pay a dividend of 0 TWD.

What is the dividend yield of U-Neuron Biomedical?

The current dividend yield of U-Neuron Biomedical is .

When does U-Neuron Biomedical pay dividends?

U-Neuron Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of U-Neuron Biomedical?

U-Neuron Biomedical paid dividends every year for the past 0 years.

What is the dividend of U-Neuron Biomedical?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is U-Neuron Biomedical located?

U-Neuron Biomedical is assigned to the 'Health' sector.

Wann musste ich die Aktien von U-Neuron Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of U-Neuron Biomedical from 12/4/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 12/4/2024.

When did U-Neuron Biomedical pay the last dividend?

The last dividend was paid out on 12/4/2024.

What was the dividend of U-Neuron Biomedical in the year 2023?

In the year 2023, U-Neuron Biomedical distributed 0 TWD as dividends.

In which currency does U-Neuron Biomedical pay out the dividend?

The dividends of U-Neuron Biomedical are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von U-Neuron Biomedical

Our stock analysis for U-Neuron Biomedical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of U-Neuron Biomedical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.